256 related articles for article (PubMed ID: 28256213)
21. Signaling pathways in Rhabdomyosarcoma invasion and metastasis.
Ramadan F; Fahs A; Ghayad SE; Saab R
Cancer Metastasis Rev; 2020 Mar; 39(1):287-301. PubMed ID: 31989508
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of impaired differentiation in rhabdomyosarcoma.
Keller C; Guttridge DC
FEBS J; 2013 Sep; 280(17):4323-34. PubMed ID: 23822136
[TBL] [Abstract][Full Text] [Related]
23. Rhabdomyosarcomas are oncogene addicted to the activation of AVIL.
Xie Z; Janczyk PL; Shi X; Wang Q; Singh S; Cornelison R; Xu J; Mandell JW; Barr FG; Li H
Proc Natl Acad Sci U S A; 2022 Jun; 119(24):e2118048119. PubMed ID: 37146302
[TBL] [Abstract][Full Text] [Related]
24. Rhabdomyosarcoma: current challenges and their implications for developing therapies.
Hettmer S; Li Z; Billin AN; Barr FG; Cornelison DD; Ehrlich AR; Guttridge DC; Hayes-Jordan A; Helman LJ; Houghton PJ; Khan J; Langenau DM; Linardic CM; Pal R; Partridge TA; Pavlath GK; Rota R; Schäfer BW; Shipley J; Stillman B; Wexler LH; Wagers AJ; Keller C
Cold Spring Harb Perspect Med; 2014 Nov; 4(11):a025650. PubMed ID: 25368019
[TBL] [Abstract][Full Text] [Related]
25. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas.
Laé M; Ahn EH; Mercado GE; Chuai S; Edgar M; Pawel BR; Olshen A; Barr FG; Ladanyi M
J Pathol; 2007 Jun; 212(2):143-51. PubMed ID: 17471488
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.
Shern JF; Chen L; Chmielecki J; Wei JS; Patidar R; Rosenberg M; Ambrogio L; Auclair D; Wang J; Song YK; Tolman C; Hurd L; Liao H; Zhang S; Bogen D; Brohl AS; Sindiri S; Catchpoole D; Badgett T; Getz G; Mora J; Anderson JR; Skapek SX; Barr FG; Meyerson M; Hawkins DS; Khan J
Cancer Discov; 2014 Feb; 4(2):216-31. PubMed ID: 24436047
[TBL] [Abstract][Full Text] [Related]
27. Rhabdomyosarcoma: Updates on classification and the necessity of molecular testing beyond immunohistochemistry.
Dehner CA; Rudzinski ER; Davis JL
Hum Pathol; 2024 May; 147():72-81. PubMed ID: 38135061
[TBL] [Abstract][Full Text] [Related]
28. [Spindle cell rhabdomyosarcoma in adults: a new entity in the spectrum of malignant mesenchymal tumors of soft tissues].
Mentzel T
Pathologe; 2010 Mar; 31(2):91-6. PubMed ID: 19997735
[TBL] [Abstract][Full Text] [Related]
29. Outcome and prognostic variables in childhood rhabdomyosarcoma (RMS) with emphasis on impact of FOXO1 fusions in non-metastatic RMS: experience from a tertiary cancer centre in India.
Ramanathan S; Sisodiya S; Shetty O; Prasad M; Parambil BC; Shah S; Ramadwar M; Khanna N; Laskar S; Qureshi S; Vora T; Chinnaswamy G
Ecancermedicalscience; 2023; 17():1539. PubMed ID: 37138963
[TBL] [Abstract][Full Text] [Related]
30. Expression of insulin-like growth factor pathway proteins in rhabdomyosarcoma: IGF-2 expression is associated with translocation-negative tumors.
Makawita S; Ho M; Durbin AD; Thorner PS; Malkin D; Somers GR
Pediatr Dev Pathol; 2009; 12(2):127-35. PubMed ID: 18788888
[TBL] [Abstract][Full Text] [Related]
31. Detection of PAX3/PAX7-FKHR fusion transcripts in rhabdomyosarcoma and other small round cell tumors by 1-step reverse transcriptase polymerase chain reaction: a novel tool for diagnosis and differentiation.
Yang XL; Zhang SC; Zhang SW; Wang H
Ann Diagn Pathol; 2012 Apr; 16(2):107-11. PubMed ID: 22197543
[TBL] [Abstract][Full Text] [Related]
32. Changes in FXR1 expression after Chemotherapy for Rhabdomyosarcoma.
Xu MC; Ghani MO; Apple A; Chen H; Whiteside M; Borinstein SC; Correa H; Lovvorn HN
J Pediatr Surg; 2021 Jun; 56(6):1148-1156. PubMed ID: 33736876
[TBL] [Abstract][Full Text] [Related]
33. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.
Williamson D; Missiaglia E; de Reyniès A; Pierron G; Thuille B; Palenzuela G; Thway K; Orbach D; Laé M; Fréneaux P; Pritchard-Jones K; Oberlin O; Shipley J; Delattre O
J Clin Oncol; 2010 May; 28(13):2151-8. PubMed ID: 20351326
[TBL] [Abstract][Full Text] [Related]
34. Rhabdomyosarcoma: How Advanced Molecular Methods Are Shaping the Diagnostic and Therapeutic Paradigm.
Giannikopoulos P; Parham DM
Pediatr Dev Pathol; 2021; 24(5):395-404. PubMed ID: 34107813
[TBL] [Abstract][Full Text] [Related]
35. Results of a prospective minimal disseminated disease study in human rhabdomyosarcoma using three different molecular markers.
Sartori F; Alaggio R; Zanazzo G; Garaventa A; Di Cataldo A; Carli M; Rosolen A;
Cancer; 2006 Apr; 106(8):1766-75. PubMed ID: 16544315
[TBL] [Abstract][Full Text] [Related]
36. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.
Sorensen PH; Lynch JC; Qualman SJ; Tirabosco R; Lim JF; Maurer HM; Bridge JA; Crist WM; Triche TJ; Barr FG
J Clin Oncol; 2002 Jun; 20(11):2672-9. PubMed ID: 12039929
[TBL] [Abstract][Full Text] [Related]
37. Detection of FOXO1 (FKHR) gene break-apart by fluorescence in situ hybridization in formalin-fixed, paraffin-embedded alveolar rhabdomyosarcomas and its clinicopathologic correlation.
Mehra S; de la Roza G; Tull J; Shrimpton A; Valente A; Zhang S
Diagn Mol Pathol; 2008 Mar; 17(1):14-20. PubMed ID: 18303411
[TBL] [Abstract][Full Text] [Related]
38. Clinical features and prognosis of paediatric rhabdomyosarcoma with bone marrow metastasis: a single Centre experiences in China.
Huang C; Jian B; Su Y; Xu N; Yu T; He L; Zhang X; Liu Y; Jin M; Ma X
BMC Pediatr; 2021 Oct; 21(1):463. PubMed ID: 34670517
[TBL] [Abstract][Full Text] [Related]
39. Detection of alveolar rhabdomyosarcoma in pleural fluid with immunocytochemistry on cell block and determination of PAX/FKHR fusion mRNA by reverse transcription-polymerase chain reaction.
Sawangpanich R; Larbcharoensub N; Jinawath A; Pongtippan A; Anurathapan U; Hongeng S
J Med Assoc Thai; 2011 Nov; 94(11):1394-8. PubMed ID: 22256481
[TBL] [Abstract][Full Text] [Related]
40. MiRNAs as Players in Rhabdomyosarcoma Development.
Gasparini P; Ferrari A; Casanova M; Limido F; Massimino M; Sozzi G; Fortunato O
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
